Abstract
Fusidic acid was assessed for antileprosy activity in nine lepromatous leprosy patients. Patients received fusidic acid at either 500 mg/day for 12 weeks or 750 mg/day for 4 weeks followed by 500 mg/day for 8 weeks. All patients showed time-dependent clinical improvement and decreases in bacillary morphological index, radiorespirometric activity and PCR signal, and in serum phenolic glycolipid I. Fusidic acid appears to be a weakly bactericidal antileprosy agent which may have a role in the multidrug treatment of leprosy pending an evaluation of lepra-reaction-suppressive activity.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bellahsène A., Forsgren A. Effect of fusidic acid on the immune response in mice. Infect Immun. 1980 Sep;29(3):873–878. doi: 10.1128/iai.29.3.873-878.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bendtzen K., Diamant M., Faber V. Fusidic acid, an immunosuppressive drug with functions similar to cyclosporin A. Cytokine. 1990 Nov;2(6):423–429. doi: 10.1016/1043-4666(90)90051-t. [DOI] [PubMed] [Google Scholar]
- Chan G. P., Garcia-Ignacio B. Y., Chavez V. E., Livelo J. B., Jimenez C. L., Parrilla M. L., Franzblau S. G. Clinical trial of clarithromycin for lepromatous leprosy. Antimicrob Agents Chemother. 1994 Mar;38(3):515–517. doi: 10.1128/aac.38.3.515. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chan G. P., Garcia-Ignacio B. Y., Chavez V. E., Livelo J. B., Jimenez C. L., Parrilla M. L., Franzblau S. G. Clinical trial of sparfloxacin for lepromatous leprosy. Antimicrob Agents Chemother. 1994 Jan;38(1):61–65. doi: 10.1128/aac.38.1.61. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cho S. N., Cellona R. V., Fajardo T. T., Jr, Abalos R. M., dela Cruz E. C., Walsh G. P., Kim J. D., Brennan P. J. Detection of phenolic glycolipid-I antigen and antibody in sera from new and relapsed lepromatous patients treated with various drug regimens. Int J Lepr Other Mycobact Dis. 1991 Mar;59(1):25–31. [PubMed] [Google Scholar]
- Farber B. F., Yee Y. C., Karchmer A. W. Interaction between rifampin and fusidic acid against methicillin-resistant coagulase-positive and -negative staphylococci. Antimicrob Agents Chemother. 1986 Jul;30(1):174–175. doi: 10.1128/aac.30.1.174. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Franzblau S. G., Biswas A. N., Harris E. B. Fusidic acid is highly active against extracellular and intracellular Mycobacterium leprae. Antimicrob Agents Chemother. 1992 Jan;36(1):92–94. doi: 10.1128/aac.36.1.92. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Franzblau S. G., Biswas A. N., Jenner P., Colston M. J. Double-blind evaluation of BACTEC and Buddemeyer-type radiorespirometric assays for in vitro screening of antileprosy agents. Lepr Rev. 1992 Jun;63(2):125–133. doi: 10.5935/0305-7518.19920016. [DOI] [PubMed] [Google Scholar]
- Gelber R. H., Fukuda K., Byrd S., Murray L. P., Siu P., Tsang M., Rea T. H. A clinical trial of minocycline in lepromatous leprosy. BMJ. 1992 Jan 11;304(6819):91–92. doi: 10.1136/bmj.304.6819.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Grosset J. H., Ji B. H., Guelpa-Lauras C. C., Perani E. G., N'Deli L. N. Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy. Int J Lepr Other Mycobact Dis. 1990 Jun;58(2):281–295. [PubMed] [Google Scholar]
- Grüneberg R. N., Emmerson A. M., Ridgway G. L. Rifampicin-containing antibiotic combinations in the treatment of difficult infections. J Antimicrob Chemother. 1984 Jun;13 (Suppl 100):49–55. doi: 10.1093/jac/13.suppl_c.49. [DOI] [PubMed] [Google Scholar]
- Hoffner S. E., Olsson-Liljequist B., Rydgård K. J., Svenson S. B., Källenius G. Susceptibility of mycobacteria to fusidic acid. Eur J Clin Microbiol Infect Dis. 1990 Apr;9(4):294–297. doi: 10.1007/BF01968066. [DOI] [PubMed] [Google Scholar]
- Kissling M., Bergamini N. Rifampicin in free combination with other antimicrobial drugs in non-Tb infections. Clinical data on 650 patients (a review). Chemotherapy. 1981;27(5):368–402. doi: 10.1159/000238006. [DOI] [PubMed] [Google Scholar]
- Shepard C. C. A brief review of experiences with short-term clinical trials monitored by mouse-foot-pad-inoculation. Lepr Rev. 1981 Dec;52(4):299–308. doi: 10.5935/0305-7518.19810040. [DOI] [PubMed] [Google Scholar]
- Shepard C. C. Statistical analysis of results obtained by two methods for testing drug activity against Mycobacterium leprae. Int J Lepr Other Mycobact Dis. 1982 Mar;50(1):96–101. [PubMed] [Google Scholar]
- Taburet A. M., Guibert J., Kitzis M. D., Sorensen H., Acar J. F., Singlas E. Pharmacokinetics of sodium fusidate after single and repeated infusions and oral administration of a new formulation. J Antimicrob Chemother. 1990 Feb;25 (Suppl B):23–31. doi: 10.1093/jac/25.suppl_b.23. [DOI] [PubMed] [Google Scholar]
- Van Caekenberghe D. Comparative in-vitro activities of ten fluoroquinolones and fusidic acid against Mycobacterium spp. J Antimicrob Chemother. 1990 Sep;26(3):381–386. doi: 10.1093/jac/26.3.381. [DOI] [PubMed] [Google Scholar]
- Williams D. L., Gillis T. P., Booth R. J., Looker D., Watson J. D. The use of a specific DNA probe and polymerase chain reaction for the detection of Mycobacterium leprae. J Infect Dis. 1990 Jul;162(1):193–200. doi: 10.1093/infdis/162.1.193. [DOI] [PubMed] [Google Scholar]
- Williams D. L., Gillis T. P., Fiallo P., Job C. K., Gelber R. H., Hill C., Izumi S. Detection of Mycobacterium leprae and the potential for monitoring antileprosy drug therapy directly from skin biopsies by PCR. Mol Cell Probes. 1992 Oct;6(5):401–410. doi: 10.1016/0890-8508(92)90034-u. [DOI] [PubMed] [Google Scholar]
- von Daehne W., Godtfredsen W. O., Rasmussen P. R. Structure-activity relationships in fusidic acid-type antibiotics. Adv Appl Microbiol. 1979;25:95–146. doi: 10.1016/s0065-2164(08)70148-5. [DOI] [PubMed] [Google Scholar]